Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 EUR | -3.00% |
|
+7.11% | -14.72% |
06-04 | Akeso Expands Territory of License Agreement for Lung Cancer Drug | MT |
06-03 | Summit Therapeutics Inc. Expands License Territories for Ivonescimab | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 9926 Stock
- 4RY Stock
- Revisions Akeso, Inc.